A new drug dubbed the “King Kong” of weight-loss jabs will be available in Ireland early next year, it was confirmed yesterday. Mounjaro, a brand name for tirzepatide, can be used to treat obesity or ...
Fast-growing drugmaker Eli Lilly and Co. would consider Wisconsin sites for new plants beyond a $3 billion project the ...
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Lilly announced in April that it agreed to acquire the manufacturing facility from Nexus Pharmaceuticals LLC. The acquisition ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday. The pharmaceutical giant plans a $3 billion investment, which is expected to create 750 new jobs at ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...
The U.K. will start offering Eli Lilly’s weight loss drug next year, but will restrict the medicine to people with the ...
Abby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she was working in medical writing, covering neurological news for healthcare professionals. She also published her ...
Also Read: 99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly’s Detailed Phase 3 Data Shows The FDA approved tirzepatide as Mounjaro for adults with type 2 ...